| NCT06247904 | NIBS Therapy in Subacute Spinal Cord Injury | Albert Einstein Healthcare Network | | - Age 18 - 80 yrs
- Level C4-C6
AIS A, B, C- All
- NOT have trauma-related brain injury
- NO history of seizures or seizure risk
| By invitation | 20 | NA | Technology | General health | - Adverse Events (AEs)
- American Spinal Injury Association Impairment Scale (AIS)
- Feasibility
- International Standards for Neurological Classification of Spinal Cord Injury (ISNCSCI)
- Motor Evoked Potentials (MEPs)
| 2 years | 09 April 2025 | 08 February 2024 | 1 | |
| NCT06661057 | Avation Electric Stimulation System for Spinal Cord Injury Neurogenic Bladder | The University of Texas Health Science Center, Houston | | - Age 18 - 75 yrs
- Level C1-T10
AIS - ≥ 6 months
| Ended | 0 | NA | Technology | Bladder health/function | - Bowel and bladder control
- Feasibility
- Incontinence Quality of Life Questionnaire (I-QOL)
- Neurogenic Bladder Symptom Score
- Neurogenic Bowel Dysfunction Score (NBD or NBDS)
- Surface Electromyography (sEMG)
| 12 weeks | 01 December 2024 | 28 October 2024 | 1 | |
| NCT06531837 | Electroencephalographic Characteristics of Chronic Pain in Patients With Spinal Cord Injury | Beijing Tiantan Hospital | | - Age 18 - 65 yrs
- Level C1-S5
AIS - All
| Recruiting soon | 60 | NA | Drug | Pain | - Generalized Anxiety Disorder (GAD-7)
- Pain Numeric Rating Scale (NRS)
- Patient Health Questionnaire-9 (PHQ-9)
| 1 week | 25 August 2024 | 01 August 2024 | 1 | |
| NCT06650202 | Improving Balance After Spinal Cord Injury Using a Robotic Upright Stand Trainer and Spinal Cord Epidural Stimulation | Kessler Foundation | | - Age ≥ 18 yrs
- Level C1-S5
AIS - ≥ 1 years
- have an implanted spinal cord epidural stimulation unit that is eligible for software upgrade as part of a previous study.
- be willing to discontinue anti-spasticity medications
| Recruiting | 20 | NA | Technology | Standing/walking/mobility | - Neuromuscular Recovery Scale
- Surface Electromyography (sEMG)
| 4 months | 01 November 2024 | 21 October 2024 | 1 | |
| NCT06677229 | Phase 1b/2a Clinical Trial to Determine the Safety, Tolerability and Efficacy of TZ-161 in Spinal Cord Injury | Technophage, SA | | - Age 18 - 65 yrs
- Level T1-T12
AIS B, C, D- ≤ 24 null
| Recruiting | 28 | PHASE1, PHASE2 | Drug | General health | | 6 months | 01 August 2025 | 06 November 2024 | 2 | |
| NCT06494059 | A Novel Repetitive Synchronized Associative Stimulation Neuromodulation Approach for Spinal Cord Injury Patients | University of Miami | | - Age 18 - 70 yrs
- Level C1-T10
AIS A, B, C, D- ≥ 6 months
- NOT have metal implants near stimulation sites (e.g., head or spine), implantable devices (e.g., cochlear implants, neurostimulators such as DBS or VNS), or cardiac devices (e.g., pacemakers or intracardiac lines)
- NOT have a traumatic brain injury, stroke, multiple sclerosis, or other disorders that could affect neuromotor function
- NOT have a history of epilepsy, convulsion or seizures
| Recruiting | 25 | NA | Technology | General health | - Motor Evoked Potentials (MEPs)
- Nine Hole Peg Test
| 2 months | 04 November 2024 | 10 July 2024 | 1 | |
